Mithra Financial Results for First-Half 2023
Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance sheet and…
Social Media
DJI Announces Mini 4 Pro Drone, Upgraded DJI Mini Series; Learn More Info at B&H
DJI upgrades the Miniseries with the release of the Mini 4 Pro drone., the DJI…
Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX)…
Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX)…
LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
TOKYO and CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo,…
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00…
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00…
Information on the total number of voting rights (denominator)
Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 –…
Information on the total number of voting rights (denominator)
Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 –…
U.S. Firms Embrace Providers of Contact Center Automation
Partner engagements are increasing as enterprises aggressively adopt AI, analytics, cloud migration, ISG Provider Lens™…
Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX)…
Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Genprex Inc. (NASDAQ: GNPX)…
LiveVox Awarded Exemplary Status in Ventana Research’s 2023 Buyers Guide for Contact Center Suites
Contact Center Innovator Recognized as a Leader for Total Cost of Ownership (TCO) and Return…
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
BOSTON and ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase…
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery (NASDAQ:…
Phrasee Appoints Dan Head as CEO to Drive Next Phase of Innovation and Growth
Head to lead effort that empowers brands with high-performing, scalable, channel-agnostic AI content they can…
Space Programme Backed by Egyptian Businessman Set to Launch Most Powerful UK Reusable Rocket – Karman Space Programme
LONDON–(BUSINESS WIRE)–#Rocket– A university space programme from London are preparing to launch the most powerful British…
Afterparty Secures $5M in Funding to Debut Afterparty AI; Enables Creators to Infinitely Scale Fan Interactions
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
Public Trust in AI Technology Declines Amid Release of Consumer AI Tools
New MITRE-Harris Poll survey finds generational and gender differences in outlook for adoption BEDFORD, Mass….